AI and blockchain could accelerate biomedical research, say Russian scientists
Insilico Medicine, the parent company of Russian biomed startup Insilico, has published a peer-review research paper calling for patients to regain control of their personal medical records, and even to profit from them. The Baltimore-based Insilico Medicine, which specializes in the application of deep learning for drug discovery, produced the paper, titled “Converging blockchain and next-generation artificial intelligence …
AI and blockchain could accelerate biomedical research, say Russian scientists Read More